28th Oct 2025 CEPHEUS study: daratumumab combination therapy for newly diagnosed multiple myeloma: plain language summary
8th Nov 2024 Final analysis of the GRIFFIN study: Daratumumab with lenalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma